31:
804:
wikipedia is the appropriate place. It is egregious use of you to be pushing for deletion of information which will be used in the education of medial diagnosis. Simply because the article is partially edited by the original source the ePLAR theory, whom has more than ample credibility as source in in the field or echo cardiology.
561:
Johnson & Johnson's ($ JNJ) Remicade that is now in line to become the second knockoff to reach the U.S. market. Biosimilar drug market is growing up every day, but there's any of these company's info. So I think it should be written in Wiki - Someone wants to know about
Biosimilar Drug companies.
406:
Flat Out: Thank you for your messages and warnings. I have made numerous edits to try to comply with the requirements. I believe that this entry is no longer promotional in nature, but I need further guidance as where the line is being crossed so that I can make further revisions. The language is
215:
Flat Out: Thank you for your messages and warnings. I have made numerous edits to try to comply with the requirements. I believe that this entry is no longer promotional in nature, but I need further guidance as where the line is being crossed so that I can make further revisions. The language is
683:
This page will showcase the new echo parameter ePLAR. The first public showing of supporting clinical data data will be at the
American College of Cardiology conference in San Diego on Monday 16.3.2015. There will be two referencable presentations/publications at that meeting. A paper is in review
560:
Hello, I witten info about
Celltrion Healthcare company located in Korea. This company's info related Biosimilar Drug just like Remsima, Johnson & Johnson's Remicade. One of the FDA's advisory committees has circled March 17 on the calendar for its review of Celltrion's Remsima, a biosimilar of
371:
since the article has been deleted I am unable to go back and look at the source, but I check it twice and
Sinocare wasn't mentioned. In any case, that one source is not enough to support notability and the mere existence on a promiment exchange does not not automatically support notability - it's
180:
since the article has been deleted I am unable to go back and look at the source, but I check it twice and
Sinocare wasn't mentioned. In any case, that one source is not enough to support notability and the mere existence on a promiment exchange does not not automatically support notability - it's
803:
i have no conflict at all. There is nothing overblown or self promoting about the ePLAR article, it simply outlines a new echocardiogram parameter which is in development, enlisting the source of the theory to validate my work and add references. As it is will not be text books for many months,
684:
at
Journal of the American Society of Echocardiography. Once these publications and presentations are released, the ePLAR will certainly be noteworthy and referencable and valid. Please allow the page to stay live until those supporting data can be added in 2 weeks time. Cheers Greg Scalia
353:
The notability guideline you cite strongly suggests a publicly traded company on a major exchange is notable. It appears you made an error when you deleted the journal article that was a reference after finding no mention of the company. In that article the company is prominently mentioned.
162:
The notability guideline you cite strongly suggests a publicly traded company on a major exchange is notable. It appears you made an error when you deleted the journal article that was a reference after finding no mention of the company. In that article the company is prominently mentioned.
705:
As noted on a comment a few minutes ago (before I logged in), supporting presentations and publications for ePLAR will be in the public domain in 2 weeks. Please allow the page to stand until that time, as it will certainly be noteworthy and referenced then Greg Scalia
438:
the issue is that you have now tried 3 times to write an article that promotes yourself. The content is unsourced and fails to meet any of the requirements of either a biography or a company. Your username is also promotional and in violation of
Knowledge policy.
247:
the issue is that you have now tried 3 times to write an article that promotes yourself. The content is unsourced and fails to meet any of the requirements of either a biography or a company. Your username is also promotional and in violation of
Knowledge policy.
863:
Hi Flat Out, I went through the username policy but was unable to understand why my name is in violation of it. Could you help me further on this please? Thank you! Also, thanks for the response to my query.
631:
638:
that Slade will be touring with the band. Do you think this will settle the dispute? If so, can the 3RR be closed without action? You can reply at the noticeboard. Thanks,
310:
is a publicly traded company of a major stock exchange of a major economy. I do not see how any company fitting that criteria should be removed by speedy delete.
119:
is a publicly traded company of a major stock exchange of a major economy. I do not see how any company fitting that criteria should be removed by speedy delete.
530:
and thanks for the question. Sources need to be able to be verified by other editors. A name doesn't give us enough information about a source that we can
463:
I have a better understanding of the violations now, and I will make the necessary adjustments to comply. Thanks for your understanding and patience.
272:
I have a better understanding of the violations now, and I will make the necessary adjustments to comply. Thanks for your understanding and patience.
733:
ePLAR is being presented at ACC meeting on the 16.3.2015. Greg Scalia is well published author/researcher on the subject of echocardiography.
407:
simply meant to describe the work of the company and its owner, not to solicit business in any way. I would really appreciate your assistance.
216:
simply meant to describe the work of the company and its owner, not to solicit business in any way. I would really appreciate your assistance.
577:
71:
514:
753:
691:
722:
64:
can you please make it clear that why the content showing 5 year back has been changed in kachhwaha and on what basis?````
479:
423:
288:
232:
596:
sources have written about the company then you might consider re-submitting an article. As it stands the company is not
825:
have written about the subject it doesn't meet wikipedia standards for notability. You might also have another read of
38:
87:
75:
573:
695:
510:
869:
657:, unfortunately Slades touring status is not in dispute. I'm not sure it is going to help..Best wishes
589:
569:
359:
315:
168:
124:
882:
865:
632:
Knowledge:Administrators' noticeboard/Edit warring#User:Wasp-1992 reported by User:Flat Out (Result: )
818:
809:
805:
769:
749:
745:
741:
710:
687:
643:
565:
502:
467:
411:
276:
220:
67:
886:
873:
848:
813:
795:
757:
726:
699:
672:
647:
615:
581:
549:
518:
483:
454:
427:
391:
363:
348:
319:
292:
263:
236:
200:
172:
157:
128:
105:
79:
471:
435:
415:
280:
244:
224:
841:
788:
718:
665:
608:
542:
447:
384:
341:
256:
193:
150:
98:
47:
17:
527:
506:
475:
419:
307:
284:
228:
116:
531:
368:
355:
326:
311:
177:
164:
135:
120:
654:
639:
90:
but I have no idea what you are talking about. I haven't edited that article in a year.
830:
597:
330:
139:
835:
826:
800:
782:
777:
773:
765:
737:
Not unfeasible to await the 2 weeks for the publication and subsequent peer review.
714:
659:
602:
536:
441:
378:
335:
250:
187:
144:
92:
822:
593:
376:
have been written about my multiple independent and secondary sources. best wishes
185:
have been written about my multiple independent and secondary sources. best wishes
46:
If you wish to start a new discussion or revive an old one, please do so on the
734:
885:
Team
Yoddhas - it implies you are representing the organisation.
25:
333:
it will survive but at the moment its not sourced at all.
142:
it will survive but at the moment its not sourced at all.
776:
and should refrain from editing the article. Please see
635:
534:that they have said/written what the article says.
821:you fail to understand how wikipedia works. Until
60:content showing in kachhwaha is irrelevant````
8:
735:http://www.pubfacts.com/author/Greg+Scalia
685:
622:How can I edit this company page notable?
65:
498:why can't i use people as references?
44:Do not edit the contents of this page.
7:
24:
372:just that most listed companies
181:just that most listed companies
29:
823:independent, secondary sources
636:the Guardian has now confirmed
626:Your 3RR complaint about AC/DC
1:
887:09:23, 27 February 2015 (UTC)
874:06:38, 27 February 2015 (UTC)
849:05:32, 27 February 2015 (UTC)
814:01:01, 27 February 2015 (UTC)
796:06:00, 25 February 2015 (UTC)
758:08:28, 24 February 2015 (UTC)
727:22:53, 23 February 2015 (UTC)
700:22:50, 23 February 2015 (UTC)
673:19:49, 13 February 2015 (UTC)
648:17:54, 13 February 2015 (UTC)
616:06:10, 13 February 2015 (UTC)
582:06:07, 13 February 2015 (UTC)
550:22:13, 5 February 2015 (UTC)
519:16:03, 5 February 2015 (UTC)
484:06:22, 5 February 2015 (UTC)
455:06:14, 5 February 2015 (UTC)
428:05:58, 5 February 2015 (UTC)
392:02:10, 5 February 2015 (UTC)
364:10:51, 4 February 2015 (UTC)
349:05:08, 4 February 2015 (UTC)
320:05:07, 4 February 2015 (UTC)
293:06:22, 5 February 2015 (UTC)
264:06:14, 5 February 2015 (UTC)
237:05:58, 5 February 2015 (UTC)
201:02:10, 5 February 2015 (UTC)
173:10:51, 4 February 2015 (UTC)
158:05:08, 4 February 2015 (UTC)
129:05:07, 4 February 2015 (UTC)
106:23:06, 1 February 2015 (UTC)
80:11:51, 30 January 2015 (UTC)
902:
630:Hello Flat Out. Regarding
772:you both have a clear
42:of past discussions.
774:conflict of interest
402:Promotional articles
211:Promotional articles
556:Deletion of Article
303:Deletion of article
112:Deletion of article
18:User talk:Flat Out
761:
744:comment added by
730:
713:comment added by
702:
690:comment added by
585:
568:comment added by
522:
505:comment added by
487:
470:comment added by
431:
414:comment added by
296:
279:comment added by
240:
223:comment added by
82:
70:comment added by
54:
53:
48:current talk page
893:
844:
843:let's discuss it
838:
791:
790:let's discuss it
785:
760:
738:
729:
707:
668:
667:let's discuss it
662:
634:. It looks like
611:
610:let's discuss it
605:
584:
562:
545:
544:let's discuss it
539:
521:
499:
486:
464:
450:
449:let's discuss it
444:
430:
408:
387:
386:let's discuss it
381:
344:
343:let's discuss it
338:
295:
273:
259:
258:let's discuss it
253:
239:
217:
196:
195:let's discuss it
190:
153:
152:let's discuss it
147:
101:
100:let's discuss it
95:
33:
32:
26:
901:
900:
896:
895:
894:
892:
891:
890:
861:
842:
836:
789:
783:
739:
708:
681:
666:
660:
628:
609:
603:
563:
558:
543:
537:
500:
496:
465:
448:
442:
409:
404:
385:
379:
342:
336:
305:
274:
257:
251:
218:
213:
194:
188:
151:
145:
114:
99:
93:
62:
30:
22:
21:
20:
12:
11:
5:
899:
897:
880:
879:
860:
857:
856:
855:
854:
853:
852:
851:
801:User: Flat Out
680:
677:
676:
675:
627:
624:
621:
619:
618:
557:
554:
553:
552:
495:
492:
491:
490:
489:
488:
458:
457:
403:
400:
399:
398:
397:
396:
395:
394:
329:, if it meets
304:
301:
300:
299:
298:
297:
267:
266:
212:
209:
208:
207:
206:
205:
204:
203:
138:, if it meets
113:
110:
109:
108:
61:
58:
56:
52:
51:
34:
23:
15:
14:
13:
10:
9:
6:
4:
3:
2:
898:
889:
888:
884:
878:
877:
876:
875:
871:
867:
858:
850:
847:
846:
845:
839:
832:
828:
824:
820:
817:
816:
815:
811:
807:
802:
799:
798:
797:
794:
793:
792:
786:
779:
775:
771:
767:
764:
763:
762:
759:
755:
751:
747:
743:
736:
731:
728:
724:
720:
716:
712:
703:
701:
697:
693:
689:
678:
674:
671:
670:
669:
663:
656:
652:
651:
650:
649:
645:
641:
637:
633:
625:
623:
617:
614:
613:
612:
606:
599:
595:
591:
590:Plutocrat2101
588:
587:
586:
583:
579:
575:
571:
570:Plutocrat2101
567:
555:
551:
548:
547:
546:
540:
533:
529:
525:
524:
523:
520:
516:
512:
508:
504:
493:
485:
481:
477:
473:
469:
462:
461:
460:
459:
456:
453:
452:
451:
445:
437:
434:
433:
432:
429:
425:
421:
417:
413:
401:
393:
390:
389:
388:
382:
375:
370:
367:
366:
365:
361:
357:
352:
351:
350:
347:
346:
345:
339:
332:
328:
324:
323:
322:
321:
317:
313:
309:
302:
294:
290:
286:
282:
278:
271:
270:
269:
268:
265:
262:
261:
260:
254:
246:
243:
242:
241:
238:
234:
230:
226:
222:
210:
202:
199:
198:
197:
191:
184:
179:
176:
175:
174:
170:
166:
161:
160:
159:
156:
155:
154:
148:
141:
137:
133:
132:
131:
130:
126:
122:
118:
111:
107:
104:
103:
102:
96:
89:
85:
84:
83:
81:
77:
73:
72:14.98.242.139
69:
59:
57:
49:
45:
41:
40:
35:
28:
27:
19:
881:
862:
840:
834:
787:
781:
740:— Preceding
732:
709:— Preceding
704:
686:— Preceding
682:
664:
658:
629:
620:
607:
601:
564:— Preceding
559:
541:
535:
528:Footballjack
507:Footballjack
501:— Preceding
497:
466:— Preceding
446:
440:
410:— Preceding
405:
383:
377:
373:
340:
334:
306:
275:— Preceding
255:
249:
219:— Preceding
214:
192:
186:
182:
149:
143:
115:
97:
91:
66:— Preceding
63:
55:
43:
37:
883:Teamyoddhas
866:Teamyoddhas
594:independant
369:Muzzleflash
356:Muzzleflash
327:Muzzleflash
312:Muzzleflash
178:Muzzleflash
165:Muzzleflash
136:Muzzleflash
121:Muzzleflash
86:I'm sorry,
36:This is an
819:TheMikol23
806:TheMikol23
770:TheMikol23
746:TheMikol23
692:93.58.60.7
655:EdJohnston
640:EdJohnston
859:User Name
837:Flat Out
784:Flat Out
766:Gmscalia
754:contribs
742:unsigned
723:contribs
715:Gmscalia
711:unsigned
688:unsigned
661:Flat Out
604:Flat Out
578:contribs
566:unsigned
538:Flat Out
515:contribs
503:unsigned
494:Question
480:contribs
468:unsigned
443:Flat Out
424:contribs
412:unsigned
380:Flat Out
337:Flat Out
308:Sinocare
289:contribs
277:unsigned
252:Flat Out
233:contribs
221:unsigned
189:Flat Out
146:Flat Out
117:Sinocare
94:Flat Out
68:unsigned
831:WP:SOCK
598:notable
592:, When
472:Tvbobme
436:Tvbobme
416:Tvbobme
331:WP:CORP
281:Tvbobme
245:Tvbobme
225:Tvbobme
140:WP:CORP
39:archive
827:WP:COI
778:WP:COI
653:thanks
532:verify
679:ePLAR
16:<
870:talk
829:and
810:talk
768:and
750:talk
719:talk
696:talk
644:talk
574:talk
511:talk
476:talk
420:talk
374:also
360:talk
316:talk
285:talk
229:talk
183:also
169:talk
125:talk
88:talk
76:talk
526:Hi
325:Hi
134:Hi
872:)
833:.
812:)
780:.
756:)
752:•
725:)
721:•
698:)
646:)
600:.
580:)
576:•
517:)
513:•
482:)
478:•
426:)
422:•
362:)
318:)
291:)
287:•
235:)
231:•
171:)
127:)
78:)
868:(
808:(
748:(
717:(
694:(
642:(
572:(
509:(
474:(
418:(
358:(
314:(
283:(
227:(
167:(
123:(
74:(
50:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.